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Multifunctional Receptor Model for Dioxin
and Related Compound Toxic Action:
Possible Thyroid Hormone-Responsive
Effector-Linked Site
by James D. McKinney*
Molecular/theoretical modeling studies have revealed that thyroid hormones and toxic chlorinated aromatic
hydrocarbons ofenvironmental significance (forwhich dioxin orTCDD is the prototype) have similar struc-
tural properties that could be important in molecular recognition in biochemical systems. These molecular
properties include a somewhat rigid, sterically accessible and polarizable aromatic ring and size-limited,
hydrophobic lateral substituents, usually contained in opposite adjoining rings ofadiphenyl compound. These
molecular properties define the primary binding groups thought to be important in molecular recognition
ofboth types ofstructures in biochemical systems. Similar molecular reactivities are supported by the dem-
onstration ofeffective specific binding ofthyroid hormones and chlorinated aromatic hydrocarbons with
fourdifferent proteins, enzymes, orreceptorpreparations that are known orsuspected to be involved in the
expression ofthyroid hormone activity. These binding interactions represent both aromatic-aromatic (stack-
ing) and molecular cleft-type recognition processes. A multiple protein or multifunctional receptor-ligand
bindingmechanism model is proposed as a way ofvisualizing the details andpbssible role ofboth the stack-
ingand clefttype molecularrecognition factors in the expression ofbiological activity. The model suggests
a means by which hormone-responsive effector-linked sites (possible protein-protein-DNA complexes) can
maintain highly structurally specific control ofhormone action. Finally, themodel alsoprovides a theoret-
ical basis forthe design and conduct offurther biological experimentation on the molecular mechanism(s)
ofaction of toxic chlorinated aromatic hydrocarbons and thyroid hormones.
Introduction
Halogenated aromatic hydrocarbons have added much
to ourmodern living and have become an important part
ofeveryday life. Because oftheir production on a large
scale andwidespread usage forthe last 30 years or more,
many ofthese persistent chemicals such as the DDTfam-
ily ofinsecticides, polychlorinated biphenyl(PCB) dielec-
tric fluids, etc., are commonly present in the environment
and its biota, including humans (1). Some of these com-
pound classes (e.g., dioxins andfurans) occur asunwanted
contaminants of the useful chemicals. These classes of
compounds are usually found as complexmixtures ofvar-
ious congeners and isomers, each with its own indepen-
dent toxic potential. The concern about the health and
ecological effects (2) ofthese persistent lipophilic chemi-
cals is due to their acute toxicity, e.g., the chlorinated
dibenzodioxins and dibenzofurans that occur as con-
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taminants of chlorinated phenol preparations, or their
chronictoxicityresultingfrombioconcentration overtime
in body tissues, e.g., PCBs, chlorinated benzenes, and
naphthalenes, as well as the dioxins and furans.
The toxicological and ecological effects ofthese chemi-
cals have been studied extensively in many laboratories
(1-3). Signs and symptoms include chloracne, weightloss,
general malaise, nausea, loss ofappetite, impairment of
liver function, hepatic porphyria, and sensory neuropa-
thy. The entire group ofchlorinated aromatic hydrocar-
bons(CAHs) showmany similarities intoxicity, with con-
siderable variation in dose-response. The contamination
with these chemicals is very extensive, and much ofthe
toxicological workhas beenrather empirical and descrip-
tive in nature. However, knowledge about their effects
on laboratory animals is advancing rapidly.
Treatment ofanimals with2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD), the prototype for certain halogenated
aromatic hydrocarbons that effect a similar pattern of
toxicity, produces divergent effects on circulating levels
ofL-thyroxine (T4) and 3,5,3'-triiodo-L-thyronine (T3) con-
centrations (4-7). These results, alongwith the lack ofin-J. D. McKINNEY
formation on thyroid hormone-modulated responses in
these animals, have caused uncertainty regarding their
functional and biochemical thyroid status. For example,
the presence ofgoiter(4)and depressed circulatinglevels
oftotal and free T4 (4-7) in TCDD-treated rats led Paz-
dernik and Rozman (8) to propose that the animals are
hypothyroid. On the otherhand, administration ofTCDD
to rats increased (9) the thyroid hormone-responsive
hepatic enzyme activity ofmalic enzyme, an effect seen
in hyperthyroidism. The hormone response in TCDD-
treated animals may reflect an adaptation to a toxic bio-
chemical lesion that occurs very early after TCDD ex-
posure (10). This in turn may reflect a direct effect of
TCDD onthyroid hormones themselves, e.g., in function-
ing as agonists and antagonists with respect to their
specific binding interactions in biochemical systems.
Because oftheir relative low toxicity, the PCBs have
been a useful model class for studying the toxicological
effects(3)ofthese chemicals inthe laboratory. Theaction
offoreign compounds such asPCBsinbiological systems
can be produced by avariety ofspecific molecular inter-
actions and combinations ofnonspecific processes. All of
these actions reflect aclose relationship between physio-
cochemical properties encoded inthe molecular structure
ofthe compounds andthe responses they evoke inbiolog-
ical systems (11). Using primarily PCBs as well-
characterized structural models, our approach was sim-
ply to determine the important structural features and
the unique stereoelectronic conditions in these molecules
that determined toxicity. This in turn should provide in-
sight into the nature oftheirbinding sites and associated
possible endogenous ligands in toxicologically relevant
biological systems.
Because of the exquisite toxicity of the parent com-
pounds, it wasreasonable toanticipate thatmuch oftheir
toxicproperties maybe the result ofover- (orunder-) ex-
pression ofnormal life-controlling biological activity. In
this article we review ourfindings and some supporting
information that webelieve indicate animportant rolefor
thyroid hormone binding sites in the expression of tox-
icity ofCAHs. We first examine the structural relation-
ship of toxic CAHs and the thyroid hormones (THs).
Model systems are described that explore the molecular
recognition processes ofboth types of structures in bio-
chemical systems. Molecular determinants ofbinding in-
teractions with proteins and model systems and the ex-
pression ofbiological activity are shown to be similar, if
not identical, for both the toxic compounds and thyroid
hormones. Finally, we propose a multifunctional recep-
tor model for CAH toxic action consistent with its nor-
mal function as a critical thyroid hormone-responsive
effector-linked site.
General Structural Relationship
The toxic CAHs and THs can be more broadly classi-
fied as halogenated aromatic hydrocarbons. Thyroid hor-
mones have the additional feature of being amino acid
analogs. The possible importance of this difference will
be discussed later. The structural resemblance ofcertain
CAHs to THs, e.g., the DDT family ofinsecticides, was
recognized manyyears ago (12), but the importance and
similarity ofspecificmolecularfeaturesforactivitywere
not clear. Thetoxicpotencyofthe CAHsvaries consider-
ably andis remarkably dependent onthe numberandpo-
sition of halogen atoms in their molecular structure.
Qualitative structure requirements for high toxicity in-
cludeplanarity orcoplanarity ofstructure in a shape ap-
proximating a rectangle and a sufficient degree ofhalo-
genation concentrated about lateral positions (e.g,
2,3,7,8-chlorines in TCDD) ofthe molecule. Halogenation,
for example, in nonlateral positions (e.g., ortho-
substitutions in PCBs)in variably decreases the biologi-
cal and toxic potency. This has led to the 3 x 10A rec-
tangular box generalization for the structure-activity
relationship (2,13-15). On the basis ofthis and other ob-
servations, we advanced the following working hypoth-
eses: a)There is a common structuralbasisforthe toxic-
ity ofmany different halogenated aromatic hydrocarbon
classes; b) a polarizable aromatic ringandlateral halogen
substituents are the primary binding groups whose
topographical arrangement is fundamental to the toxic-
ity ofthese compound classes; c) stereoelectronic factors
determine the extent of their relevant binding interac-
tions which in turn determine toxic potency; d) these
same structural features are represented by the polariz-
abletyrosylringandthe diiodophenolicmoietyofthethy-
roid hormones.
Clearly, ifthese hypotheses (Fig. 1) could be verified,
then they wouldprovide the basis for an extremely use-
ful common toxicophore foruse in mechanism-based tox-
icityprediction and assessment. We provide evidence in
the form of molecular and theoretical modeling studies
that common structural featuresbetweenTHs and CAHs
do existand arerepresented intheirbinding interactions
with proteins and related model systems. Such interac-
tions between CAHs and thyroid hormone binding pro-
teins in biological systems may mediate the expression
ofpotent andpersistent thyroid hormone agonist and an-
tagonist activity that could underlie toxicity.
Itwasrecognized sometime ago (16)thatspecific struc-
tural and stereochemical features of the THs were
responsible for their hormone action. Thyromimetic ac-
tivity is directly related to the ability of the sterically
large 3,5 substituents to constrain the diphenyl ether
thyronine nucleus to the two approximately energetically
equal, readily interconvertible, proximate, and distal con-
formers(two rings are disposednearlyperpendicular and
bisecting, and the 3' and 5'positions become nonequiva-
lent with respect to the alanine-bearingring). Thisgives
rise to the conceptofapreferred, thoughnot rigid, orien-
tation ofthe molecule, described as a skewed conforma-
tion(17). Early work(18) has shown that aromatic char-
acter for the alanine-bearing (tyrosyl) ring may be
important for thyromimetic activity, and it was sug-
gested(16) that thebulky3,5 substituents, in addition to
positioning the outer (phenolic) ring, together with the
methylene group of the alanine side chain provide en-
hancement of the binding characteristics of the tyrosyl
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FIGURE 1. Common structural properties for thyroxine and toxic chlo-
rinated aromatic hydrocarbons. Reprinted with permission (69).
ring to some biologic receptor through their electronic
contributions. We have recently suggested that the
polarizability of the 3,5 substituents may contribute to
the overallhydrophobic property ofthetyrosylring(19).
The 3,5-iodines may serve both torestrict the overall con-
formation and increase molecular polarizability of the
tyrosyl ring, specifically facilitating hydrophobic (perhaps
stacking in nature) interactions. Thus, although in the
overall structure the tyrosyl and phenolic rings are not
coplanar, the tyrosyl ring does present a sterically and
energetically accessible planarface forpossible stacking
interactions with other aromatic moieties. In addition, it
is clearthat size-limited hydrophobic associations involv-
ing phenolic ring substituents are also important in the
expression ofhormonal activity(16). There are also defi-
nite structure-activity relationships associated with var-
iations in the amino acid side chain, but it is not clear to
what extent these are direct effects on binding interac-
tions versus indirect effects, e.g., on the hydrophobic
properties of the tyrosyl ring (20).
Forhighly active (ortoxic) structures inboththe CAH
and TH series, there is an apparent need for a sterically
and energetically accessible, polarizable aromatic ring
coupled with hydrophobic substituents in the lateral po-
sitions of the adjoining rings. If these features of the
molecules are aligned(Fig. 1), there is an overall similar-
ity in geometrical size and shape of the molecules and
close correspondence oftheplanarfaces and lateral sub-
stituents. On the basis of these preliminary molecular
comparison studies, itwaspossibletopostulate two ma-
jor types of molecular recognition processes in bio-
chemical systems thatmightmediate theirbiological ac-
tivities. The firstwould involve dispersion-stacking type
interactions between polarizable planarfaces ofaromatic
rings. Likelybinding sites inproteinsforstackinginter-
actions are the rigid side chains ofaromatic amino acids
(21), as well as the heme prosthetic group in hemopro-
teins. Recent crystallographic studies(22-23) have shown
that stackinginteractions between aromatic amino acids
and DNAbases are important recognitionfactors inthe
interactions ofproteins andnucleic acids. The secondtype
ofinteraction would involvemolecularcleft-type interac-
tions (24) between highly polarizable lateral halogen
atomsandthe hydrophobic interiorofthe cleftprovided
by amino acid side chains that converge on the halogen
substituents. The importance ofC-shaped molecular cavi-
ties or clefts with viselike properties in molecular recog-
nition has been recognized (25).
The question arises as to whether both ofthese struc-
turally distinctrecognition sites are components ofa sin-
gle, multifunctional bindingprotein orwhetherthey are
found in different proteins, perhaps involving the lipid
phasethat cooperates inthebindingprocess andultimate
expression ofbiological activity. For example, it has re-
cently been suggested (26) that the direct ligand recep-
tormodel might be replaced in some casesby amultiple
sequential step model in which the bindingenergy from
membrane interaction is used to overcome the entropy
requirement for bringing the ligand-receptor together.
Regardless ofwhichofthesepossibilities is correct, there
are likely to be molecules that are efficiently recognized
(perhapscooperatively)bybothsites,whileothers areef-
ficiently recognized by only one of the sites. Such site
selection differences(27)mightprovide aplausible basis
forunderstandingpartial agonist andantagonistproper-
ties ofsome compounds. We now examine some molecu-
lar models that have been developed to support the im-
portance ofthese molecularrecognitionprocesses inthe
expression of biological activity by CAHs and THs.
Stacking Models
The toxic and induction responses ofCAHs at the cel-
lularlevel have beenproposedtoinvolve specific, satura-
ble, noncovalent binding of the soluble Ah (or dioxin)
receptor. Therole oftheAhreceptorproteininthemech-
anismofaction oftoxic CAHshas beenthroughlyinves-
tigated(13-15,28)andsatisfiesmostofthe specificcriteria
that support areceptor-mediated cellularprocess. Apla-
nar(orenergeticallyfavorable coplanar)aromatic system
is the primary structural feature that is found in all
known high-affinity ligands for this receptor, which in-
clude both halogenated and nonhalogenated aromatic
compounds. Theoretical modeling (29-32) of CAH-Ah
receptor interactions based on experimental competitive
binding studies support a stacking interaction model in
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which the CAH molecular polarizability and CAH to
receptor equilibrium separation distance are the impor-
tant molecular parameters. For two structurally related
CAHs (one being a reference compound, CAH1), the ra-
tio ofequilibrium binding constants for receptor binding
simplifies to give
KjK1 ~ exp [3ctR E/(4kT)(-ac/re6 (1)
a /r6 )I
Here k is Boltzmann's constant, T is absolute tempera-
ture, E, and average excitation energy, is given by
E = E1ER/(E1 + ER)
TCDD Porphine 3.38 A
0
c
H:~~~~
Hexachlorobiphenyl Porphine 3.50 A
(2)
where Ei and ER are excitation energies for the CAH
class andreceptor, respectively, and aR, al andai are the
polarizabilities of the receptor, a reference CAH and
CAHi, respectively; re isthe equilibrium receptorto CAH
separation distance. Modeling results have been inter-
preted in terms oflinear free-energy relationships. Since
polarizability and distance parameters are exponential
functions in the equilibrium equation, small differences
can have large effects on binding. The polarizability com-
ponent in the lateral direction of these basically
rectanglar-shaped molecules isusually dominant and can
be enhanced significantly by the addition oflateral halo-
gens. Therefore, it is understandable in this model how
lateral halogenation can lead to increased binding activ-
ity. The advantage of this model is that it incorporates
the stereoelectronic effects of chlorine substitution on
binding free energy (Fig. 2).
Although the molecular structure of the Ah receptor
binding site is not known, the modeling results support
the importance of a stacking mechanism in the molecu-
lar recognition process. The PCB ortho effect is readily
apparent in such amodelbecause it canhave asignificant
effect on the PCB-to-receptor separation distance that af-
fects bindingactivity. We have usedporphine as amodel
forthe receptorbinding domain, although an alternative
hydrophobic region on a protein may be the rigid indole
side chain nucleus of the tryptophan residue. Such a
stackingmodel is reminiscent ofthose drawn for charge-
transfer complexes, and polarization ofthe PCB molecule
by the electronic environment ofthe binding site would
be relevant. Evidence that these halogenated aromatic
hydrocarbons may act as electron-acceptors in charge
transfercomplexwiththeAhreceptor hadbeenprovided
(14,33).
What can be predicted from such a model in terms of
the types ofstructures that should showgood binding ac-
tivity? A somewhat rigid and accessible planar face
characteristic of a phenyl ring is of obvious importance
in effecting close contactwith a similarface in the recep-
torbinding site. Theimportance ofaromatic-aromatic in-
teractions inprotein stability and function hasbeenreal-
ized (13). Both parallel stacking and perpendicular
stacking arrangements are energetically favorable and
Cl
ClCIC
Pentachlorobiphenyl Porphine 3.47 A to 3.80 A
Ci
FIGURE 2. Computergraphics model from molecularmechanics minimi-
zation of porphine interactions with various chlorinated aromatic
hydrocarbons with equilibrium separation distances in angstroms.
Reprinted with permission (31).
observable (34,35). Ofequalimportance isthe polarization
of this face in a direction that will bring about a good
donor-acceptor relationship as in a charge-transfer com-
plex. The inductive and resonant effects ofhalogen sub-
stitution can effectively polarize the aromatic system.
CAHs could be viewed overall as having electron-poor
faces with areas of significant hole density along the
edges, particularly in hydrogen substituted positions;
conversely, possible donoraromatic compounds could be
viewed as havingelectron-rich faces with areas ofsignif-
icant electron density alongthe edges, particularly in as-
sociation with nitrogen and oxygen atoms. For example,
a more favorable donor-acceptorinteractionmay account
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inlarge partforthe relatively muchlowertoxicity ofthe
chlorinated naphthalenes as compared with the signifi-
cantly more polarizable brominated naphthalenes (14).
Directional fusing ofphenyl rings as in polynuclear aro-
matic hydrocarbons can also effect similarpolarization of
the molecule (36).
The fundamental requirement for good binding activ-
ityis aconformationally restricted (somewhat rigid), ster-
ically accessible andhighlypolarizable planar (aromatic)
ring. The critical factors are apparently the direction and
degree of polarizability necessary to facilitate efficient
electron acceptance by theringsystem(orelectronaccep-
tance by ringedges). This canbe accomplished in smaller
ring systems with the larger and more polarizable halo-
gen atoms, i.e., bromine andiodine. These predictions are
consistent with arange ofexperimental competitivebind-
ing studies involving various Ah receptor preparations
and a variety of both nonhalogenated and halogenated
aromatic hydrocarbons, some significantly smaller than
PCBs (13,37,38). Other workers (39) have also stressed
the importance ofaromatic-aromatic interactions in the
binding sites of cytochromes P-448 (to which the Ah
receptor isrelated). Although experimentally, hydroxy-
CAHs have relatively much lower bindingaffinitiesthan
theirhalogen substituted counterparts, the model would
predict that this is due to large differences in aqueous
desolvation energy(because ofthe potential forhydrogen
bonding) rather than to differences in intrinsic binding
properties (29). This technical problem would limit the
range ofligands thatcouldbe studied ininvitro inexperi-
ments.
We have also examined the possibility that THs might
also be able to bind by a stacking complexation mecha-
nism (19). The potential of thyroid hormone analogs to
form charge-transfer complexes involvingthe substituted
phenolate ion and selected acceptors was recognized
some time ago (40), but the physiological importance of
such complexes remains unclear. In contrast, the poten-
tialofTHstohavelarge electron affinities wasalsorecog-
nized early (41). Using methods based on nuclear mag-
netic resonance (NMR) spectroscopy, we showed that
selected, structually distinct thyroid hormone analogs
with widely different hormonal activities functioned as
electron acceptors inmolecular complexes with aromatic
donors involving the nonphenolic or tyrosyl ring (19) of
THs. Interestingly, relative binding free energies for
these complexes correlated well with those previously
reported (42) for the triiodothyronine (L-T3) nuclear
receptor binding interaction with the same compounds.
AspredictedbytheAhreceptormodelingwork, smaller
ring systems that have a highly polarizable planar face
can effectively participate in equilibrium stacking inter-
actions.
Ofparticularinterest to structure-activity similarities
between CAHs and THs was the recognition that al-
though iodine is not directly involved, it can facilitate
binding interactions of a charge-transfer type in the
tyrosyl rings of thyroid hormone analogs (43). The
3,5-iodines serve not only to sterically constrain (making
it more rigid) the diphenyl ether thyroxine nucleus to
facilitate a stackinginteraction with the tyrosyl ringbut
alsoto increase the electron-acceptor strengthofthe ring
through theirpolarization properties. Electron-accepting
ability may also be further enhanced by the
hydroquinone-type property of the adjoining ether-
oxygen-phenolic ring system (16). Therefore, in
diphenylether systems (such as the chlorinated diphenyl-
ethers)related to THs, it isreasonable to expect that the
morebiologically active compounds will also contain sub-
stitutions (in positions equivalent to the 3,5 positions in
THs)that restrict conformational space through hinder-
ing rotation about the ether linkage. The toxic CAHs
generally are more rigid structures that already have an
entropy advantage in stacking-type binding interactions.
Infact, anaccessible andhighlypolarizable aromatic ring
system characteristic oftoxic CAHs is also characteris-
tic of the tyrosyl ring of THs and represents the fun-
damental molecular element ofimportance in our NMR
bindingmodel (19) as well. Binding ligands forthe T3 nu-
clear receptor and the Ah receptor may share common
molecularparameters in the expression oftheirbinding
activities. The tyrosyl ring could be envisioned as pre-
sentingapolarized surface tothereceptor,whichthenad-
heres to the receptor somewhatlike Velero, analogous to
the CAH interaction shown in Figure. 2.
Cleft Models
Aspolarizability is roughlyproportional to the number
ofelectrons, the stacking model can reasonably account
for the number and kinds of halogen substituents in
highly toxic structures. It cannot accountfor theprefer-
enceforlateral substitution andrectangularshape. Itwas
recognized (20) some time ago that the o-diiodophenolic
structure ofTHs is very important in theirbindinginter-
actions with serum transport proteins. Considerable
knowledge has beengained ofthe high-resolution X-ray
crystallographic structure of one of the transport pro-
teins, thyroxine binding prealbumin (TBPA) or trans-
thyretin. A well-developedpicture atthe molecularlevel
ofthebindinginteractions between hormone andTBPA
(44) has also provided a model against which all other
binding associations of the hormones and their analogs
will be compared and contrasted. Studies of TBPA and
the thyroid hormone nuclearreceptorsuggested the pos-
sibility ofa closerrelationship between the twoproteins
than would have been anticipated, which suggests that
the studies on TBPA may have a direct bearing on the
properties of the nuclear receptor (45,46).
Prealbumin from human plasma is a tetramer ofiden-
tical subunits of 127 amino acid residues of known se-
quence (47) giving an Mr ofthe tetramer as 54 980. Aro-
matic pair amino acid interactions in TBPA that appear
to play an important role in protein structure stabiliza-
tion(21) and DNA interactions(22,23)may also facilitate
the abilityofthese types ofproteins to sequesterCAHs.
Recent work (48) has established that human, rat, and
rabbitTBPA are more than80% identical and allresidues
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in the binding site are conserved. The four identical
subunits are oriented to form a central channel contain-
ingtwoidentical 14 binding sites. Themolecule has2-fold
symmetry, and the binding site is lined primarily with
hydrophobic amino acid side chains thatformpolarizable
pockets for halogen interactions. The binding site
matches the structure andchemistry ofthe hormonewith
greatprecision, which together with the fact that TBPA
almost completely engulfs the hormone, probably ac-
counts for the high association constant. Thus the hor-
morebinding siteinTBPArepresents analmostidealized
case of a molecular cleft with complementarity in size,
shape, andfunctionalgroupsforefficientmolecularrecog-
nition (24,25,49). Competitive binding studies (50,51) us-
inghumanTBPAandpolar(soluble) derivatives ofdioxin
and related polychlorinated biphenyl compounds have
shownthat simple halogenatedhydrocarbons that contain
only one aromaticring orlinear structures withmultiple
rings bind more strongly than the normal angular
diphenylether bridged system characteristic ofthyroid
hormone analogs. Furthermore, lateral chlorination was
common to all compounds that showed high binding ac-
tivity. The bindingmodel infact suggested a preference
for alinear and symmetrical molecular shape like TCDD
(Fig. 3A). These structural properties are also charac-
teristics of highly toxic CAHs (13-15).
Computer graphics modeling ofthe ligand-TBPA com-
plexes has beenparticularly useful in visualizing the im-
portance of lateral substitution and a linear and sym-
metrical molecular shape. In view of the highly
hydrophobic/polarizable nature ofthebinding site, itwas
anticipated thatthe van derWaals/hydrophobic interac-
tions would be dominant in controlling the binding
strength of these compounds. In this simple modeling
(docking) exercise, a correspondence between the bind-
ing efficacy of each compound and the total number of
contacts lessthan4Abetweenthe compound andprotein
molecular surface was assumed. Figure 3A shows aclose
correspondence ofthe 2,3-lateral chlorine substituents in
TCDD with the diiodophenolic moietyofthyroxine inthe
binding site. A similar fitisfound forthe2,3-lateral chlo-
rine substituents in TCDF or 3,5-lateral (meta) chlorine
substituents in 3,31,4,4',5,5'-hexachlorobiphenyl (Fig. 3B),
whereas the 2,21,4,4',6,6'-hexachlorobiphenyl lacking
meta-substituents (Fig. 3C) shows a relatively poor fit.
Outerring(nearest to entrance ofbindingchannel)lateral
substitution is not critical forPCB binding to TBPAand
may evenlowerbindingaffinity(50). Deviation from alin-
ear shape as in the 1,4,6,9-substituted dioxin case (Fig.
3D) could lead to bad(repulsive) contacts due to the col-
liding or short contacts between molecular surfaces. A
theoretical model based on molecular mechanics energy
minimization procedures(52) was developed (53)forthis
bindinginteraction withTBPAwhichpermits one to es-
timate the differential free energies ofcomplexformation
for compounds ofthis type for which it may be difficult
or impossible to obtain experimental binding data. The
theory correctly separates stro.ng, intermediate, and non-
binders in caseswhere experimental values were known.
In addition, the theory predicts that TCDD and TCDF
would be strong binders and that octachlorodibenzodi-
oxin, a 1,4,6,9-substituted dioxin, would not bind at all.
These results also suggest that the assumptions made in
ourearlier molecularmodelingexercises are reasonable
and support the use of such models for preliminary
screening purposes.
Model Predictions and Tests
No endogenous physiologic ligand for the Ah receptor
has yet been clearly identified. TheAh receptor system
enhances enzyme activities (37) that often are far more
important in toxification than in detoxification, and
thereby contributes to a process ostensibly contrary,
rather than advangtageous, to life. The Ah receptor
seems likely to have beneficial functions that outweigh
its disadvantageous effects. The stacking models
described above for CAHs suggests thatthe nonphenolic
(tyrosyl) ring of THs appears to be suitable (somewhat
rigid, sterically accessible aromatic ringthat ispolariza-
ble) for undergoing a stacking interaction of the type
described fortheAh receptor interaction (19). For tech-
nicalreasons(29), ithasnotbeenpossible to demonstrate
directlythatTHswill compete with 3H-TCDD usingcon-
ventionalAhreceptorbindingassays. Undermorephys-
icallyfavorable conditionsbasedon theuse ofnonionicde-
tergent micelles (54), the THs can compete with
dioxin-type ligands specifically bound to sites in ratliver
cytosolpreparations. Wehaverecentlydemonstrated(38)
moderate specific binding affinity of diiodobenzenes (as
models for THs) withAh receptor preparations. In addi-
tion, both theAh andT3 receptors show a strong depen-
dence ofbindingactivity onhydrophobicpropertiesofthe
bindingligands(55,56) and on dilution, temperature, and
pH properties ofthe assayitself(57,58). Tissue distribu-
tion ofthetwo receptors inthe ratis also similar(59,60),
andthe relative levels ofreceptors inthe varioustissues
are consistent with the known thyroid hormone respon-
siveness ofthese tissues(59). Finally, certaintoxic effects
ofboth THs and CAHs segregate with the Ah gene lo-
cus(forwhichtheAhreceptoristhegeneproduct)in cell
culture systems (61). Thus, several lines ofevidence are
suggesting that the Ah receptor has properties in com-
mon with the nuclear triiodothyronine (T3) receptor.
Because ofthe structural similarities between certain
CAHs and THs and the consistent finding of serum T4
reduction in toxicity studies (4-7,62) with dioxin and
related compounds, our results with the serum binding
protein TBPA are not surprising. In addition to the
modeling aspects of the TBPA interactions presented
above, itislikelythatinteractions ofCAHswiththyroid
hormone serum-binding proteins play a direct role in
mediatingcertaintoxic effects ofdioxin andrelated com-
pounds, e.g., inmediatingvitamin Adepletionintissues
(63,64). Certain CAHs may interfere with a major func-
tion of TBPA in facilitating uniform distribution of T4
amongall cells within each tissue (65). Previous workers
(66)have alsoprovided evidencefora structural similar-
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FIGURE 3. Computer graphic models ofligand-TBPAbindingpocket complexes. Pictures show cross-section ofsolvent-accessible molecular surfaces
ofthe model-builtbinding site(viewisperpendicular to plane ofinnerring). The TBPA surface is blue. (A)Superposition structure ofT4(green)
from X-ray and TCDD or dioxin (red) from docking; (B) docked 3,3,',4,4', 5,5'-hexachlorobiphenyl; (C) docked2,2',4,4',6,6'-hexachlorobiphenyl;
(D) docked 1,4,6,9-tetrachlorodibenzo-p-dioxin.
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ity between the binding sites of prealbumin and
thyroxine-5'-deiodinase found in tissues. The structure-
activity relationship for 11 iodothyronine analogues act-
ing as inhibitors for rat liver deiodinase activity was
statistically correlated with theirbinding affinities to hu-
man TBPA. Similarly, recent preliminary work (67) in
our laboratory has demonstrated potent inhibition of
deiodinase activity in rat liver microsomal fractions by
certain CAHs in the dioxin and PCB series. This inhibi-
tion depended on the presence oflateral chlorination con-
sistent with ourcompetitive bindingstudies usingTBPA.
Interestingly, flavone natural products derived from
plant pigments are also inhibitors ofdeiodinase activity
(11), as well as binding ligands for the Ah receptor (37).
As pointed out earlier, TBPA and at least one thyroid
hormone nuclear receptor have a considerable number of
theirproperties in common orhave aspects ofsimilarity
(44,45). These similarities include similar molecular
masses, similar overall chemistry ofthe thyroid hormone
binding sites, similarbindingaffinities forthe hormones
and analogs, and both may be DNA binding proteins.
Families of proteins do exist in which, within a single
broad function, individual members are subtly orgrossly
modified to fulfill specific functions, andthe identification
and analysis ofsuchfamilies is ofmuchimportance inun-
derstanding biological processes. Inthisregard, previous
workers (68) have provided experimental evidence for a
prealbuminlike receptor thatperforms agene-activating
function in cell cytosol sensitive to thyroid hormones.
These workers found that the specific cytosol protein ac-
quired the necessaryproperties forinteracting with cer-
tain chromatin DNA sites afterbindingthyroid horrnone.
Binding ofthe hormone-receptor complexwith the DNA
sites resulted in the initiation of gene transcription.
In our laboratory (69), we have demonstrated that
prealbuminlike thyroxine-specific bindingsites inratliver
nuclear extracts have the expected structural specificity
and sensitivity forpossible involvement in the high tox-
icity ofCAHs. In addition to the requirement forlateral
chlorination forhighbindingactivity, the nuclearrecep-
tor showed aremarkably enhanced affinity forlaterally
substituted compounds that were also planar (or had
energetically favorable coplanar conformations) and
highly polarizable. For example, 3,31,5,5'-tetrachloro-
4,4'-dihydroxybiphenyl showed a remarkably high af-
finity (Ka = 5.86 x 10'0M-1) while the isomeric, but
diortho-substituted compound, 2,3,5,6-tetrachloro-4,4'-di-
hydroxybiphenyl, that cannot achieve coplanarity,
showed an affinity about 22 times weaker. The rigid
coplanar structure 3,3',5,5'-tetrachlorodiphenoquinone
(reasonably isosteric with TCDD) showed an affinity
about 3.2 times stronger. As in our previous work with
TBPA(50,51)the use ofpolar derivatives was technically
necessary in order to achieve sufficient solubility in the
assay medium and reduce nonspecific binding interac-
tionsprobably involvinglipid-rich sites. Therefore, a nu-
clear thyroxine receptor appears to have properties in
common with both TBPA and the Ah receptor, which is
also compatible with itspossible role inmediating some
of the toxic effects of these compounds.
Possible Biological Significance-
Multifunctional Ligand-Receptor
Complex
Molecular modeling studies have revealed that CAHs
and THs have similar structural properties that couldbe
important for molecular recognition in biochemical sys-
tems. These molecular properties include a somewhat
rigid, sterically accessible aromatic ringthat is polariza-
ble and size-limited, hydrophobic lateral substituents,
usually containedinopposite adjoiningringsofadiphenyl
compound(butmaybe foundinbothrings). Theseproper-
tiesaremostoftenhighlyexpressed(inthe case ofCAHs)
in fairly rigid, rectangular-shaped molecules like TCDD.
Molecular size can vary as long as there is sufficient ex-
pression ofthese fundamental molecularproperties to ef-
fect significant binding interactions. Similar molecular
reactivities are supportedby the demonstration ofeffec-
tive specific binding ofboth types of structures (CAHs
andTHs)withfour differentproteins, enzymes, orrecep-
torpreparations). Three ofthese systems are knownthy-
roid hormone-binding proteins. This observation, along
with otherevidence presented, raises thepossibility that
the Ah receptor may also be a thyroid hormone binding
protein. The structural relatedness ofTCDD to THs has
recentlybeen suggested(70) in support ofthe likelihood that
the Ah receptor will ultimately be part ofthe hormone-
responsive transcription factor super-family.
The overall structural requirements revealed in these
modeling and binding studies are compatible with the
known structure-toxicity relationships forthe CAHs. The
question remains as to whetherthese distinct molecular
recognition properties for activity are associated with
multiple binding sites in different acceptorproteins orin
the same protein. In either case, multi-functional binding
or amultiple sequential step protein-protein interaction
mechanism involving different structural components of
the molecule offers an attractive hypothesis and would
build in considerable structural specificity for the control
process. A similar mechanism ofmetabolite transfer by
enzyme-enzyme complexformationhasalreadybeenpro-
posed (71). As a working model (Fig. 4), we have sug-
gested (62) that a cytosol acceptor protein may initially
complex with thyroid hormone through a stackinginter-
actionwith thetyrosylring. This complexinturn istrans-
located to the nucleus where the lateral substituents on
thephenolic ring serve toprobethe chromatin surface for
nuclear acceptor sites that are complementary with the
cytosol acceptor complex and permit protein-protein in-
teractions to occur(Fig. 5A). Thus, the thyroid hormone
structure can be viewed as providing a steering mecha-
nism for assembling the protein-protein-DNA complex
that may be involved in initiating gene expression. This
model is also compatible with recent independent work
(72) that suggests that protein dimers involving two dif-
ferent proteins may be the entity that interacts with
DNA and regulates gene expression. This receptor com-
plexmodel forTHs is similarto thatproposedby others
(16) based primarily on structure-activity considerations.
TCDD can similarly fulfill this role (Fig. 6) with the dif-
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P - T4,T3 , P+T4.T3
Cell
Proliferation
FIGURE 4. Mechanistic model for thyroid hormone action (T3/T4) based on cooperative protein (AhIPA) binding in cytoplasm and nucleus of cell.
ference being perpendicular stacking or edge-on align-
ment with the cytosol acceptor site (Fig. 5B) as opposed
to parallel stackingasin the case ofthyroid hormone. The
somewhat rigid planar structure in TCDDjuxtaposes the
important bindinggroups in complexation. The alignment
shown in Figure 5Bsuggests thatthemajorpoints ofcon-
tact between the TCDD structure and the putative aro-
matic donor face in the cytosol acceptor site are the
hydrogen atom and lateral carbon edges. This is compat-
ible with previous theoretical work (33) investigating the
electronic factors affectingreceptorbinding ofdioxins to
the Ah receptor.
The most significant relationship with observed activ-
ity was with a lowest unoccupied molecular orbital hav-
ing significant areas ofhole density about the hydrogen
atom andlateral carbon edges. TCDD hasfourequivalent
edges of this type and additional chlorine substitution
would reduce this number. This is consistent with the
reduced receptor binding and toxicity observed for the
more highly chlorinated 2,3,7,8-substituted dioxins. Al-
though the specific details ofsuch interactions involving
TCDD and related compounds are not known, there are
clearly several possible modes ofaromatic-aromatic inter-
action that could lead to favorable stabilization energies.
As discussed previously, the cytosol acceptor protein
maybe the Ahreceptor, which maybe athyroid hormone
bindingprotein. In this capacity, theAhreceptor canplay
amodulatingrole, perhaps in controlling access to more
critical receptor sites in the nucleus ofcells. Such a gat-
ing mechanism for the Ah receptor in modulating cellu-
larbiologic and/or toxic responses to CAHswould be con-
sistent with the many studies supporting anessential(but
notnecessarily sufficient) role forAhreceptorbindingin
the mechanism oftoxicity. Other indirect evidence that
supports multiple protein involvement in the mechanism
oftoxicity ofCAHs include the observations that struc-
turally related compounds can produce both synergistic
(14) and antagonistic (73) effects on biological/toxic
responses ofthese compounds, a combination and specific
ratio ofthyroidhormones T3 andT4 arerequired tomimic
certain toxic responses of dioxin (61), and no single pro-
teinbinding model can account for the structure-toxicity
A
B
FIGURE 5. Ligand-receptor model showing multifunctional binding of
(A) T4 or (B) TCDD by cytosol (stacking) and nuclear (cleft interac-
tion) protein binding sites facilitating protein-protein interactions.
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FIGURE 6. Mechanistic model for dioxin (Dx) toxicity showing multiple proteinbinding with Ah receptor and prealbuminlike, DNA-binding nuclear
receptor (R.) Reprinted with permission (62).
relationship for CAHs without invokingmultiple ormul-
tifunctional protein binding ofligands that are both pla-
nar(or coplanar as in PCBs) and have lateral halogen sub-
stituents (69,74). Independent studies (75,76) of the
thyroid hormone nuclearreceptor are suggesting that it
may also be a multimeric species complexed with DNA.
In addition, it has been suggested (77) that Ah receptor
function requires the contribution of(atleast )twogenes.
One interpretation ofthese latter studies is that one gene
encodes for one functional unit ofthe receptor complex,
perhaps the cytosol acceptor, and a secondgene encodes
for another binding unit, perhaps nuclear in origin. The
Ahreceptormaybeneitherentirely cytosolic norentirely
nuclear but exists in equilibrium between the two com-
partments.
The molecular modeling studies with THs and CAHs
better portray CAHs as T4 agonist/antagonist rather
than T3 agonist/antagonist, especially withregard to the
correspondence oflateral substituents. This presents two
problems within the frameworkofcurrentthinking about
the mechanisms ofthyroid hormone action and our mul-
tifunctional binding model. First, it isgenerally accepted
that the active thyroid hormone is T3, which is derived
from T4 from metabolism in tissue. However, there are
several lines ofevidence (78) which suggest that T4 has
intrinsic hormonal activity. In otherwords, T3 is consid-
ered tobe themajor contributor to thehormonalpotency
ofTHs, but T4 alsocontributes directly otherthanbyfirst
undergoing metabolic conversion to T3.
Butthemultifunctional mechanism model offers an al-
ternative explanation for this apparent discrepancy. It is
known that the cellular ratio of T3 to T4 is about 4 to 1
(79). This ratio may be important in maintainingthe con-
centration gradient between the cytoplasm and the nu-
cleusinordertomaximizenuclear receptoroccupancy by
T4 andthe associatedbiologicalresponse. This canresult
fromtheapparenthighercapacity andaffinity ofcytosolic
sites for T3 but greater overall affinity (net gain ofbind-
ing free energy over that for T3) of T4 to the cytosol-
nuclearacceptorcomplex inthe nucleus. Given externally
T3 would always appear to be more active because it is
more efficient at displacingendogenous T4 toward the nu-
cleus (Fig. 4). T3 through its displacing action on T4 in
cytosol is in effectpotentiatingthe effects ofT4 in the nu-
cleus. If TCDD is a structural surrogate for T4 as sug-
gested inthis work, then T3 should alsopotentiate the ef-
fects ofTCDD as has been shown (61). Thus metabolism
ofT4 to T3 in tissues coupledwith the concentrationgra-
dient between cytoplasm and nucleus can provide a
means for regulating nuclear receptor occupancy. This
brings into question the nuclear versus cytosolic origin
ofthe T3 receptor. In fact, recent studies (80) with thy-
roidhormnone analogsarenow suggestinganextranuclear
site of initiation ofthyroid hormone effects.
The importance ofT3 relative to T4 inthyroid hormone
action is largely attributed to its greater hormonal
332TCDD/T4 ACTION REGULATED BY SIMILAR RECEPTOR COMPLEXES
potency when studied in vivo and its greater binding af-
finity to the nuclearthyroidhormone receptor in invitro
studies. As suggested above, the greater hormonal
potency is subjectto a different interpretation in the mul-
tifunctional model and may reflect the greater efficiency
ofT3 (as a metabolite) in displacing cytosolic T4 toward
the nucleus. The interpretation ofinvitro binding studies
involving crude receptor preparations can also be ques-
tioned (81). For example, depending on experimental con-
ditions, it may notbe possible to distinguish between the
binding to specific receptor sites(that may be multimeric
in nature) and nonspecific binding in which acceptor or
recognition sites (such as the disassociated units of the
multimeric receptor complex) are involved. Consistent
with this interpretation, cross-competition studies(82)in-
volving 1251I-T3, 125I-T4, and 125I-rT3 (reverse T3 or
3,3',5'-triiodothyronine) show different structural speci-
ficities indicating different binding sites in the nuclear
preparations. Ifmultifunctional binding ofT4 (Fig. 5A)is
required for agonist activity, then rT3 would be expected
to function as a partial agonist-antagonist. This result
wouldbe expected since removal ofone iodine atom from
the tyrosyl ring would decrease its polarizability and
simultaneously lower its rigidity both factors thus
weakening (relative to T4) any potential stacking inter-
action with the cytosol acceptor site while having little
orno effect on the phenolic ring interaction with the nu-
clear site (69). Preferential metabolism of T4 to rT3 (in-
stead ofT3) would then provide a very effective means
for regulating thyroid hormone activity since it reduces
the concentrationofboth T4 andT3 available to receptors
while simultaneously generating a competitive an-
tagonist. Consistent with this expected result is the re-
centfinding (83)thatrT3 can antagonize thyroid hormone
responses at almost equimolar(physiological) concentra-
tions in fetal mouse liver. Similar structural arguments
based on the model can be made to explain the ability of
certain CAHs (61,73) to antagonize dioxin (or thyroid hor-
mone) toxic effects.
At least one ofthe nuclear sites may correspond to the
c-erb-A protein that has recently been identified (84,85)
as a high affinity thyroid hormone nuclear receptor.
These studiesprovide thefirst direct evidence ofa causa-
tive involvement ofenhancers and their bindingproteins
in oncogenic transformation. The c-erb-Aprotein is simi-
lar in molecular mass to the nuclear-specific bindingpro-
tein in ratliverthatwe have shown(69) specificallybinds
both THs and CAHs isosteric with TCDD. Futhermore,
workers(86) have recently provided evidence that TCDD
causes increases in expression of c-erb-A and levels of
protein-tyrosine kinases in selected tissues ofresponsive
mouse strains. It has also been demonstrated (8?) that
THs can play a critical role in induction of neoplastic
transformation by chemical carcinogens in tissue culture.
It is perhaps not surprising in this overall context that
TCDD can act as a tumor promotor (88). TCDD may
mimic the dramatic effects ofTH in possibly regulating
transcriptional activity of one or more protooncogenes
(89) (such as the Ah receptor) during exposure to car-
cinogen.
The second apparent problem with the multifunctional
model is the factthatthe tyrosyl ring ofTHs must main-
tain a perpendicular relationship to the plane of the
TCDD molecule, forexample, ifthe close correspondence
ofthe lateral substituents is to be met (Fig. 7A). As was
stated earlier, both perpendicular and parallel stacking
interactions involving aromatic rings are energetically
favorable processes and with otherthingsbeingequal (or
nearly equal) this does not represent a major structural
difference from a molecular reactivity and recognition
point ofview. Infact, the conditions are favorableforper-
pendicularedge-to-edge or edge-to-face interactions to oc-
curwith TCDD andrelated compounds(21-23). Itispos-
sible that initial binding to the cytosol acceptorunit may
involve parallel stacking (Fig. 2) and on forming the
cytosolnuclear acceptor complex (Fig. 5B)perpendicular
stacking or edge-on alignment is necessary to facilitate
interaction with the nuclear acceptor unit. In this sequen-
tial step mechanism, a planar(or coplanar) structure that
can undergo both parallel and perpendicular stackingin-
teractions would take on added significance in determin-
ing binding affinity. PCBs that can assume a coplanar
structure (30) canbehave similarly (to TCDD)but some-
what lower binding affinity is consistent with a small
energy cost in overcomingthe small rotational barrierto
coplanarity. In the multifunctional binding model (Fig.
5B), the conformationally restricted, noncoplanar (30,32)
ortho-substituted PCBs would experience more difficulty
(in stereoelectronic and energetic terms)in accommodat-
ing simultaneously the two different types ofmolecular
recognition processes (Fig. 7B).
It has also been suggested(90)that certain chlorinated
diphenyl ether compounds may produce some of their
toxic effects through their thyromimetic properties as
predicted (62) from our modeling studies. Active struc-
tures in addition to being conformationally restrictecf
(contain ortho-substitutions in relation to the ether oxy-
gen bridge) would also contain lateral substitutions and
assume conformational structures similar to that illus-
trated for THs (Fig. 5A).
Summary
In summary, amultifunctional receptorcomplexoffers
a way ofvisualizing the details and possible role ofboth
the stacking and cleft type molecularrecognition factors
inbiological activity andprovides a sense ofdirection for
the design and conduct offurther biological experimen-
tation on the mechanism(s) of action of CAHs and THs.
The multifunctional ligand-receptor model concept should
also be considered in the study ofstructure-activity rela-
tionships and mechanisms of action for other hormonal
systems such as the steroid hormones. It may be of
general importance in maintaining highly structurally
specific control ofhormone action at effector-linked sites.
Hormonal synergists and antagonists may reflect
differential involvement of the various multifunctional
binding groups in the receptor system.
Certain toxic CAHs possibly as a result of their high
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A
B
FIGURE 7. Stereopair superposition of(A) 3,3',4,4',5,5'-HCB (heavy line) and T4 (light line) along with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD,
medium line) showing close correspondence oflateral substituents and perpendicular relationship ofother phenyl rings and (B) 2,2',4,4',6,6'-HCB
(heavy line) and T4 (light line) and TCDD (medium line) showing lack of correspondence of lateral substituents and perpendicular relationship
ofphenyl rings in the HCB and inaccessibility to stacking interactions. Reprinted with permission (50).
affinities to both T3 and T4 receptors and resistance to
metabolism are able to override normal control mecha-
nisms for the expression of thyroid hormone activity.
Toxic CAHs may act as potent and persistent thyroid
hormone nuclear receptor agonists andproduce some of
their effects by altering gene expression in susceptible
cells. There are a number ofwell-documented examples
ofthe regulation ofsingle and multiple clusters ofgenes
through multiple hormonal interactions (91). Thyroid hor-
mones are involved in the ultimate expression ofthe tar-
get genes in several of these multihormonal regulating
systems. The thyroid hormone agonist property wouldbe
compatible with the ability of CAHs to alter receptor
coupling or the receptor number for diverse hormones
(92). This is supported by recent studies suggesting that
THs in combination with CAHs can produce synergistic
effects (63,93). These effects would resemble those seen
in hyperthyroidism. Other nonreceptor effects of these
compounds which may precede the effects on gene ex-
pression could be associated with theirthyroid hormone
antagonist properties, directly, e.g., byinteractions with
certain serum binding proteins (94) and metabolizing en-
zymes (67), or indirectly, e.g., by reducing the availabil-
ity of T4 as an amino acid analog. These latter effects
should be expected to resemble those seen in
hypothyroidism. Previous studies (6,95) attempting to as-
sess the functional thyroid status of dioxin treated rats
do notconsiderthepotential complexinterplay ofthethy-
roid hormone agonist and antagonist effects of dioxin.
The overall pattern of thyroid-hormone modulated
responses seen in dioxin-treated animals such as effects
on hepatic enzyme activities (95) are characteristic ofef-
fects seen in both primary hyper- and hypothyroidism.
Dioxin toxicity should not be expected to completely
resemble the effects produced in experimentally induced
hyper- or hypothyroidism alone. Thyroid hormone
agonist and antagonist properties ofCAHs are compati-
ble with the overall toxic/biologic effects of these com-
pounds which are in many respects characteristic ofboth
the hyper- and hypothyroid disease states. Further bio-
logical verification of the multifunctional receptor com-
plex andmechanistic hypothesis for CAH toxicity is nec-
essary.
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